Title : Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy.

Pub. Date : 2015 Nov

PMID : 26398317






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with anti-CD20-hIFNalpha sensitized the cells to apoptosis by CDDP, doxorubicin and Treanda. Doxorubicin keratin 20 Homo sapiens